Epidermal growth factor receptor in non-small cell lung cancer
- PMID: 25870793
- PMCID: PMC4384217
- DOI: 10.3978/j.issn.2218-6751.2015.01.01
Epidermal growth factor receptor in non-small cell lung cancer
Abstract
Following the identification of a group of patients in the initial tyrosine kinase inhibitor (TKI) trials for lung cancer, there has been detailed focus on which patients may benefit from inhibitor therapy. This article reviews the background, genetics and prevalence of epidermal growth factor mutations in non-small cell lung cancer (NSCLC). Additionally, the prevalence in unselected patients is compared against various other reviews.
Keywords: Lung neoplasms; carcinoma; epidermal growth factor; non-small cell lung cancer (NSCLC); receptor.
References
-
- Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011;61:69-90. - PubMed
-
- Travis WD, Brambilla E, Konrad Müller-Hermelink H, et al. eds. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press, 2004:1.
-
- Devesa SS, Bray F, Vizcaino AP, et al. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005;117:294-9. - PubMed
-
- Boyle P, Levin B. eds. World Cancer Report 2008. World Health Organization, 2008:1.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials